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Abstract
Background: Rates of mental health disorders are significantly greater in children with physical illnesses than in
physically well children. Children with neurological conditions, such as epilepsy, are known to have particularly high
rates of mental health disorders. Despite this, mental health problems in children with neurological conditions have
remained under-recognised and under-treated in clinical settings. Evidence-based guided self-help interventions are
efficacious in reducing symptoms of mental health disorders in children, but their efficacy in reducing symptoms of
common mental health disorders in children with neurological conditions has not been investigated. We aim to
pilot a guided self-help intervention for the treatment of mental health disorders in children with neurological
conditions.
Methods/design: A pilot randomised controlled trial with 18 patients with neurological conditions and mental
health disorders will be conducted. Participants attending specialist neurology clinics at a National UK Children’s
Hospital will be randomised to receive guided self-help for common mental health disorders or to a 12-week
waiting list control. Participants in the treatment group will receive 10 sessions of guided self-help delivered over
the telephone. The waiting list control group will receive the intervention after a waiting period of 12 weeks. The
primary outcome measure is reduction in symptoms of mental health disorders. Exclusion criteria are limited to
those at significant risk of harm to self or others, the presence of primary mental health disorder other than anxiety,
depression or disruptive behaviour (e.g. psychosis, eating disorder, obsessive-compulsive disorder) or intellectual
disability at a level meaning potential participants would be unable to access the intervention. The study has
ethical approval from the Camden and Islington NHS Research Ethics Committee, registration number 14.LO.1353.
Results will be disseminated to patients, the wider public, clinicians and researchers through publication in journals
and presentation at conferences.
Discussion: This is the first study to investigate guided self-help interventions for mental health problems in
children with neurological conditions, a group which is currently under-represented in mental health research. The
intervention is modular and adapted from an empirically supported cognitive behavioural treatment. The
generalisability and broad inclusion criteria are strengths but may also lead to some weaknesses.
Trial registration: Current Controlled Trials: ISRCTN21184717. Registered on 25 September 2015.
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Background
Around 15 % of young people have a long-term physical
health condition [1]. Rates of mental health disorders
are significantly greater in children with physical illnesses
than in healthy controls [2, 3], and those with neurological
conditions have up to a ninefold greater risk of emotional
and behavioural disorders [4]. There are usually multiple
reasons for the association between physical and mental
health. Physical and mental health conditions may share
the same underlying pathology, particularly in neuro-
logical conditions, such as epilepsy [4, 5]. Furthermore,
children with physical illnesses face a number of chal-
lenges, such as maintaining a medication regime, being
unable to participate in physical activity and feeling differ-
ent or isolated from their peers [6]. This stress on the indi-
vidual and his/her family [7] may put the child at greater
risk of mental health disorders [8]. The relationship
between epilepsy and behavioural and emotional symp-
toms is complex, as such symptoms may be affected by
medications [9], surgery [10] and seizure location/activ-
ity. Children and young people with epilepsy are also
more likely to have autism spectrum disorder [11], at-
tention deficit hyperactivity disorder (ADHD) [12] and
intellectual disability [13], conditions which themselves
are associated with a greater risk of mental health
disorders [14].
Not only does mental illness have considerable con-
sequences for a child’s quality of life and behavioural/
educational and social functioning [15, 16], but mental
ill health has, in turn, also been shown to affect man-
agement and medical consequences of the physical
illness. For example, mental illness has been linked to
greater frequency of seizures in epilepsy [17].
There are numerous highly effective evidence-based
interventions for mental health disorders in children and
young people; one review found 750 treatment protocols
for evidence-based treatments of mental health disorders
in children [18]. The National Institute for Health and
Care Excellence (NICE) recommends the use of psycho-
logical therapies for common mental health problems in
children, e.g. group or individual parenting interventions
for children with disruptive behaviour disorders [19] and
cognitive behavioural therapy (CBT) for anxiety and
depression [20, 21]. However, there is limited guidance
on the use of these therapies in children with physical
illness, and in many cases there remains a large unmet
need. For example, Ott and colleagues [22] found that of
114 children with epilepsy, 61 % had psychiatric diagnoses,
but, of these, only 33 % had received treatment, despite
regularly attending clinics for their epilepsy. A recent
review of the psychiatric aspects of childhood epilepsy
[23] concluded that ‘the psychiatric problems in children
with epilepsy have remained under-recognised and under-
treated in clinical settings’. There is little existing research
on the utility and efficacy of evidence-based therapies for
children with mental health disorders and neurological
conditions [24]. There is a need to improve the uptake of
evidence-based therapies for children with mental health
disorders and neurological conditions.
One way of meeting a large need for psychological ther-
apy is through the use of guided self-help interventions. A
recent meta-analysis of psychotherapy for depression and
anxiety disorders in adults found that guided self-help
interventions and face-to-face interventions are equally
efficacious. A second systematic review demonstrated that
the use of guided self-help interventions may be effective
in adults with physical health problems [25], and such
interventions including guided self-help and computerised
CBT are recommended for adults with long-term physical
health conditions and depression [26]. Guided self-help
interventions have been shown to be beneficial in redu-
cing symptoms of anxiety, depression and behavioural
problems in children without physical illness [27–32].
Parent-delivered self-help interventions are appropriate
for children aged 7–12 years old [29–31], whereas self-
help conducted directly with the patient is recommended
for those aged 13 and older [32, 33]. Guided self-help may
be especially beneficial to people with physical illnesses,
due to their potential difficulties in travelling to appoint-
ments. Additionally, children with neurological conditions
are likely to have multiple medical appointments and
must also attend school, and scheduling a time to meet
with a therapist may be difficult in this context.
There has been no research to date examining the effi-
cacy of self-help interventions in reducing symptoms of
common mental health disorders in children with neuro-
logical conditions. The aim of this research is to conduct a
pilot study to investigate the efficacy of guided self-help
for symptoms of common mental health disorders in
children with neurological conditions, in a preliminary
randomised controlled trial (RCT) design. Compared to a
waiting list control, we anticipate that children who receive
guided self-help will demonstrate clinically significant
reductions in anxiety, depression and disruptive behaviour,
through parent-report measures (primary outcome mea-
sures). We also predict that following completion of
guided self-help, children will demonstrate improvements
in quality of life, also through parent-report measures.
Aims
The study aims to pilot an intervention in a group of
attendees at a tertiary paediatric neurology service. As a
pilot RCT, the main aim of this study is to inform a
future powered RCT. We will investigate whether the
components of the study work effectively together, esti-
mate recruitment and retention rates and determine the
expected effect size for the primary outcome measure
[34]. We will also aim to investigate acceptability to young
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people and families of both the study design (e.g.
randomisation, measures, etc.) and the intervention for
impairing symptoms of anxiety, depression and disruptive
behaviour disorders.
Methods/design
Study design
The study is a pilot RCT conducted at Great Ormond
Street Hospital (GOSH), UK. Eligible children attending a
neurology clinic and who have impairing symptoms of
common mental health disorders (anxiety, depression and/
or disruptive behaviour) will be randomly allocated to
either (1) receive guided self-help for their mental health
disorder over 12 weeks or (2) remain on a waiting list
for 12 weeks with no additional intervention. Children
randomised to the waiting list condition will be offered
the guided self-help intervention at the end of 12 weeks.
All participants will complete follow-up assessments at
4 and 12 weeks post-intervention (Fig. 1). Methods are
in accordance with the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
statement (Additional file 1).
Population and recruitment process
The sample will consist of children aged 7–18 years
attending a neurology clinic waiting for/undergoing
assessment or treatment at GOSH, who are identified as
meeting criteria for impairing symptoms of anxiety,
depression or disruptive behaviour. Children will be
recruited across all neurology clinics at GOSH with
Fig. 1 Flow chart of study process
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the exception of migraine, neurodisability and multiple
sclerosis clinics for practical reasons. The children will
therefore have a range of neurological conditions, includ-
ing epilepsy, cerebrovascular conditions and brain tu-
mours. Inclusion and exclusion criteria are listed in
Table 1. It is possible that children and young people
attending neurology clinics may in fact be in the process
of obtaining a diagnosis and may have no underlying
neurological condition. As a tertiary centre, many patients
may come to GOSH due to a complex presentation where
the diagnosis is unclear. Most patients attending neur-
ology clinics at GOSH have diagnoses of epilepsy. How-
ever, among these patients, some with a diagnosis of
epilepsy may also have non-epileptic seizures (in combin-
ation with epileptic seizures or separately). Given this
significant overlap, and as the purpose of this study is to
widen access to therapy, we did not want to impose an
arbitrary inclusion/exclusion criterion of a diagnosed
neurological condition, so that treatment would not be
delayed for those who could potentially benefit.
Information leaflets will be sent out with clinic
letters to all children aged 7–18 attending neurology
clinics at GOSH. Notices will be posted in the clinic
waiting rooms, informing patients of the project and
providing contact details. A researcher will be present
at the clinic and will spend at least 15 minutes with
each child/family, taking time to further explain the
study and answer any questions that potential partici-
pants may have. The researcher will obtain informed
consent/assent at this point, for those children and
families who agree to participate.
Sample size
One of the primary aims of this pilot trial is to estimate
the effect size to inform a future full-scale trial. Sample
size is therefore estimated from the expected recruit-
ment rate and thus the possible number that can be
recruited in one year (the length of the study).
There are 5195 neurology clinic sessions with 2755
patient referrals at GOSH per annum, of which we esti-
mate that two-thirds will fall within the correct age
range as patients are seen routinely throughout their
childhood (n = 1837), and based on clinic data, 15 % will
cancel/not attend appointments (n = 1561). Of those
attending, around 25 % will have an intellectual disability
that will mean they are excluded according to criterion 2
in Table 1 [29], leaving n = 1170. Assuming 50 % agree
to participate (average screening consent rate from
Bennett et al., 2015 [24]), we aim to consent 585 partici-
pants to the initial screening.
Based on population rates, we conservatively estimate
that 10 % of those screened will have a mental health
condition warranting intervention (i.e. 59; [35]). Estimat-
ing that 66 % will complete the full Development and
Well-Being Assessment (DAWBA) [36], around 39 will
be potentially eligible for the full intervention. Of these,
40 % (16) may already be receiving input from mental
health services [22], leaving 24 young people who are
potentially eligible. We estimate that 75 % of these will
agree to participate (n = 18 children and young people;
the mean agreement for intervention rate from Bennett
et al., 2015 [24]).
We will only recruit participants whilst there is
capacity for intervention. If there is a point at which
capacity is almost reached, recruitment and screening
will be suspended accordingly. In order to estimate
capacity, we will determine a priori how much time each
therapist can commit and therefore how many patients
they can support per week.
Intervention
Guided self-help arm
The guided self-help is based on the Modular Approach to
Therapy for Children with Anxiety, Depression, Trauma,
or Conduct Problems (MATCH-ADTC) [37]. This com-
bines modules for the treatment of anxiety, depression and
behaviour problems, taken from known evidence-based
protocols, with an empirically derived algorithm for
making decisions regarding which module should be used
and when. It is particularly suitable for populations with
significant comorbidity, as is seen in young people with
epilepsy and other neurological conditions. The main tech-
niques that will be used are parent-delivered CBT for
anxiety, problem solving for depression and parent train-
ing approaches for externalising difficulties. The adapted
treatment package has been piloted with six children and
Table 1 Inclusion and exclusion criteria
Inclusion criteria
1. Young people aged 7–18 years.
2. Waiting for/undergoing assessment or treatment in a neurology
clinic at Great Ormond Street Hospital.
3. Identified as meeting criteria for symptoms of common mental
health disorders (i.e. anxiety, depression or behavioural problems).
Exclusion criteria
1. Children/families who do not speak/understand English well
enough to access the screening assessments and interventions.
2. Children who have a learning disability at a level meaning that
they cannot access the screening and/or intervention. This will
be determined by clinical judgement, either prior to recruitment,
if the child is already known to GOSH, or at the initial assessment
for guided self-help. This will not be defined by IQ, but by clinical
judgement; children will not be excluded because they have a
learning disability per se, but because they are unable to access
the materials. Ability to participate may be different for younger
children, whose parents complete the materials, compared to
older children, who need to complete the materials themselves.
3. Children who screen for a severe mental health disorder other
than depression, anxiety or disruptive behavioural disorders or
whose screening is otherwise suggestive of risk will be excluded
and referred to other services as appropriate.
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young people with co-occurring mental health problems
and neurological disorders. The treatment package has
been revised and updated based on the findings of this
pilot data and from feedback from children, young people
and their families. For example, following feedback from
families that one of the worksheets in the section on inter-
vention for behavioural difficulties was confusing, this
worksheet was removed from the self-help materials.
In line with previous research, the guided self-help will
take the format of one face-to-face assessment and 10
telephone sessions over 12 weeks.
Waiting list control arm
Children allocated to remain on the waiting list will be
offered the guided self-help intervention after 12 weeks.
Participants on the waiting list will be given details of
whom to contact in an emergency (and how to recog-
nise signs of risk) should the symptoms of mental
health disorders become significantly worse during this
time period. This is in accordance with usual care. Chil-
dren will be fast-tracked to appropriate services should
significant risk be identified in this time period, in accord-
ance with best practice guidance.
Training, supervision and treatment adherence
Supporters assisting the guided self-help will be trained
to deliver the treatment protocol. All therapists will
receive weekly supervision from an experienced clinical
psychologist. Adherence to the treatment protocol will
be measured using a standardised rating scale [25].
Outcome measures
Strengths and Difficulties Questionnaire
The Strengths and Difficulties Questionnaire (SDQ) [38]
is a 25-item psychometrically robust questionnaire used
for the identification of common mental and behavioural
symptoms in young people. The SDQ is one of the most
widely used measures of childhood psychopathology in
the UK. It has been chosen as the primary outcome meas-
ure since it measures depression, anxiety and behavioural
difficulties and can therefore be used by the entire sample.
It has excellent reliability and validity [38].
Development and Well-Being Assessment
The DAWBA [39] is a computerised clinical assessment
which generates ICD-10/DSM-5 psychiatric diagnoses.
Parent measures alone are completed for children aged
10 and younger. Parent and child measures are com-
pleted for those aged 11 and over. The SDQ forms part
of the DAWBA.
Revised Children’s Anxiety and Depression Scale
The Revised Children’s Anxiety and Depression Scale
(RCADS) [40] is a 47-item questionnaire with robust
psychometric properties used to assess depression and
anxiety in children and young people.
Pediatric Quality of Life Inventory Generic Core Scales
The emotional functioning (five items) and physical func-
tioning (eight items) subscales of the Pediatric Quality of
Life Inventory (PedsQL) [41] will be used to examine
quality of life. The PedsQL has excellent reliability and
validity [35]. There are different versions of the PedsQL
for different age ranges (young children aged 5–7; children
aged 8–12; teens aged 13–18). The appropriate question-
naire for the age of the child will be used.
Additionally, we will record each participant’s IQ. Rele-
vant medical details will be recorded, including specific
neurological diagnoses, duration of neurological symp-
toms, medication or other relevant medical interventions
at assessment, pre-intervention/post-waiting list, post-
intervention and follow-up time points. These variables
will be examined as potential moderators of outcome.
Assessments
Assessment will be at screening, baseline, end of waiting list
(for those in the waiting list control arm), end of treatment
and at follow-up at 4 and 12 weeks post-intervention.
Screening and eligibility assessment
All children meeting inclusion criteria and who consent
to participate will be screened using the computerised
SDQ before completing the full DAWBA. The compu-
terised SDQ and DAWBA will be completed either at
home or in the neurology clinics at GOSH, depending
on the patient/family’s preference.
Baseline assessment (plus post-waiting list assessment for
those allocated to waiting list control)
All families in the intervention arm will complete a
clinical assessment. This will be a face-to-face assess-
ment with the family (or young person alone if appropri-
ate), completed by a qualified clinical psychologist. The
child’s paediatrician or other members of their care team
will be consulted as necessary. Paper copies of the
RCADS and PedsQL will be completed at this point.
End-oftreatment assessment
End-of-treatment assessment will include completion of
endpoint measures (DAWBA incorporating SDQ, PedsQL,
RCADS and Experience of Service Questionnaire).
Follow-up assessments
Follow-up assessments will include completion of follow-
up measures at 4 and 12 weeks after completion of the
intervention (SDQ, PedsQL and RCADS).
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Session-by-session measures
Families will also complete session-by-session outcome
measurements, in accordance with the Children and Young
People’s Improving Access to Psychological Therapies
(CYP-IAPT) data specification [42]; these will include
a brief symptom-specific measure and goal-based out-
come rating.
Randomisation, blinding and code-breaking
Participants identified by the DAWBA and clinical
assessment as experiencing impairing symptoms of men-
tal health disorder and neurological conditions will be
randomised to (1) guided self-help for their mental ill-
ness over 12 weeks or (2) remaining on the waiting list
for guided self-help with no additional intervention over
12 weeks. Stratified by type of mental health disorder
(anxiety, depression or disruptive behaviour), partici-
pants will be randomised 1:1 to the treatment arms
using random blocks. An independent researcher will
provide the randomisation codes, hold them and break
the code following completion of the trial.
Adverse events
All adverse events observed by the study team or reported
by participants will be reported to the ethics committee.
In the event that significant risk or a mental health diffi-
culty that is not appropriate for guided self-help is
detected, through any phase of the treatment, participants
will be referred to other services as appropriate. This may
include referral to local child and adolescent mental health
services, general practitioner, GOSH mental health
services or paediatric psychology, for example. The study
team may also contact the duty clinician where appropri-
ate if immediate action is required. The study team will
arrange for follow-up appointments or telephone calls
until the risk is adequately managed, consistent with
best practice guidance [43]. If the intervention is not
successful and the child is in need of further, higher
intensity treatment, then a referral will be made to
the appropriate service.
All serious adverse events will be reported in accordance
with Good Clinical Practice guidelines and local policies,
including being reported to the local research and devel-
opment team and ethics committee within 24 hours of the
study team becoming aware of the event.
Statistical analysis
Primary endpoint efficacy analysis
As a pilot, the study is not powered to detect a statisti-
cally significant difference between the intervention and
waiting list groups. Instead, we will use the results to
estimate the effect size of the difference in order to in-
form a power calculation for a planned full-scale RCT.
All analyses will be carried out on an intention-to-treat
basis and will be blind to treatment assignment. Treat-
ment groups will be descriptively compared on all base-
line measures. No interim analyses are planned, but
outcome at the end of treatment will be evaluated prior
to data lock for follow-up data. The primary analysis will
use the end-of-treatment SDQ assessment to compare
the intervention and waiting list control groups. A linear
regression adjusting for baseline assessment of the SDQ
and other baseline measures for which imbalance is
evident will be used to evaluate the intervention effect.
Whilst we recognise that the SDQ is not as sensitive at
detecting change as other measures such as the RCADS,
it is the only measure which is able to detect change
across all of the symptoms addressed within the study
(anxiety, depression and behavioural difficulties). As diag-
nosis may be an important moderator of treatment out-
come, we will conduct sensitivity analyses by analysing
young people with confirmed epilepsy diagnoses (assumed
to be the largest subset of participants) separately.
Follow-up data
Outcome analyses will follow the pattern of those of the
primary endpoint. Outcomes will be reported in accord-
ance with the Consolidated Standards of Reporting
Trials (CONSORT) statement.
Collection of feasibility data
In order to inform a larger trial, we will collect data on:
 Recruitment rates
 Data completion rates
 Intervention completion rates
 Average length of support sessions
 Acceptability of the intervention
 Time taken to complete measures
Qualitative analysis
We will interview children and young people and their
families and clinicians about their experiences of the
study and the intervention, including suggestions for
improvement. These data will be analysed thematically.
Ethics and dissemination
Ethical approval
This study has been reviewed and approved by the
Camden and Islington Research Ethics Committee (regis-
tration number 14.LO.1353). All participants will receive
verbal and written information about the study, and all
patients must give written informed consent before inclu-
sion and randomisation. The study has been registered with
the Current Controlled Trials register (ISRCTN21184717).
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Informed consent
Participants will be informed that their participation is
voluntary and that they can withdraw at any time with-
out providing a reason and without their medical care or
legal rights being affected. Participants will be given the
opportunity to ask any questions, and only when all of
their queries have been answered will consent/assent be
taken by the principal investigator or a suitably qualified
delegated member of the research team. The participant’s
informed consent will be obtained from all parents and/or
carers of children taking part in the study. Where possible,
older children and young people will provide informed
consent and younger children will provide informed assent.
Ethical and safety considerations
It is possible that the questionnaires, assessment and
intervention may cause participants and/or carers to be-
come distressed. The research team is made up of a
number of clinically trained researchers, who will be
well-placed to manage this distress should it arise and to
signpost to sources of support (such as local mental
health services) if necessary. Some participants will be
randomised to remaining on the waiting list. However,
all children will eventually receive the guided self-help
intervention. We are not depriving any children of an
intervention that they would otherwise have received.
Patient confidentiality and data protection
Patient identifiable data, including initials, date of birth
and NHS number will be required for the registration
process. The study team will ensure that the partici-
pants’ anonymity is maintained. The participants will be
identified only by initials and a participant ID number
on the case report form (CRF) and any electronic data-
base. All documents will be stored securely and will be
accessible only by study staff and authorised personnel.
The study will comply with the Data Protection Act,
which requires data to be anonymised as soon as it is
practical to do so.
Dissemination plan
During the study, a public website will be launched and
made available to participants and the health care pro-
fessionals involved. It will include information and
updates about the progress of the study. The results will
be published in peer-reviewed scientific journals and will
be disseminated at relevant research conferences and via
internal reports. Written feedback will be provided to
patient support groups.
Discussion
This is the first study to investigate guided self-help in-
terventions for mental health problems in children with
neurological conditions — a group which is currently
under-represented in mental health research. The inter-
vention is modular and adapted from an empirically
supported cognitive behavioural treatment. The general-
isability and broad inclusion criteria are a strength but
may also lead to some weaknesses, including the possi-
bility of a child not having a confirmed neurological
diagnosis and no standardised measure of physical
health. In addition, this initial study will be based within
a specialist hospital, which may limit generalisability.
However, it also has a number of strengths, including
random allocation and blinding of study assessors, en-
hancing internal validity of the results. It aims to be as
generalisable to routine clinical practice as possible and
has minimal exclusion criteria. In addition, the outcome
measures used are those used in UK National Child and
Young Persons Improving Access to Psychological Ther-
apies (CYP-IAPT) services, allowing results to be com-
pared to those across Child and Adolescent Mental
Health (CAMH) services nationally.
We anticipate the study will yield important infor-
mation on the feasibility of a large-scale study to assess
the clinical and cost-effectiveness of guided self-help
for common mental health disorders in the context of
neurological illness.
Trial status
Recruitment began in January 2015 and recruitment to
the study is due to end in January 2016 with all partici-
pants completing follow-up by August 2016.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents*. (DOC 122 kb)
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